Home » Topics » Disease categories and therapies » Immune

Immune
RSS

KRP-203 increases allograft survival in rat models of chronic rejection

Feb. 4, 2005

Prochymal receives fast track designation for acute GVHD

Feb. 3, 2005

New compounds for immune-mediated diseases designed at Merck

Feb. 2, 2005

New indications approved for Neoral and Sandimmun in Japan

Feb. 2, 2005

A novel series of immunosuppressants described in patent literature

Jan. 31, 2005

OM-197-MP-AC induces maturation of dendritic cells in vitro

Jan. 21, 2005

Pharmexa inlicenses Antigenics' QS-21 adjuvant

Jan. 20, 2005

Parenteral glutamine reported to increase hsp70 levels in critically ill patients

Jan. 19, 2005

Altastaph reported to shorten hospital stay in adult patients with S. aureus bacteremia

Jan. 19, 2005

Novartis discloses sphingosine-1-phosphate receptor modulators

Jan. 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...